Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,231 public trials 1,018 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

Efficacy and Safety of BI 2536 in Advanced or Metastatic Non Small Cell Lung Cancer

NCT00376623

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • 1216.9.49002 Boehringer Ingelheim Investigational Site Freiburg im Breisgau, Germany
  • 1216.9.49007 Boehringer Ingelheim Investigational Site Gauting, Germany
  • 1216.9.49008 Boehringer Ingelheim Investigational Site Großhansdorf, Germany
  • 1216.9.49001 Boehringer Ingelheim Investigational Site Heidelberg, Germany
View Trial Details
Completed

Study of Avelumab and Cetuximab Plus Gemcitabine and Cisplatin in Participants With NSCLC

NCT03717155

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Semmelweis Egyetem - Pulmonologiai Klinika Budapest, Hungary
  • Debreceni Egyetem - Tudogyogyaszati Klinika Debrecen, Hungary
  • Petz Aladar Megyei Oktato Korhaz - Pulmonologiai Osztaly Győr, Hungary
  • Markusovszky Egyetemi Oktatokorhaz Szombathely, Hungary
View all 20 locations
View Trial Details
Completed

A Dose-Finding Study of the Second Mitochondrial Activator of Caspases (SMAC) Mimetic Debio 1143 When Given in Combination With Avelumab to Participants With Advanced Solid Malignancies and to Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Platinum-Based Therapy

NCT03270176

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Cross Cancer Center Dept Medicine Edmonton, Alberta, Canada
  • British Columbia Cancer Agency Vancouver, British Columbia, Canada
  • Juravinski Cancer Centre Hamilton, Ontario, Canada
  • The Ottawa Hospital Cancer Centre (TOHCC) Ottawa, Ontario, Canada
View Trial Details
Completed

PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies

NCT03365791

Conditions
Adenocarcinoma Of Esophagus, Advanced Well-differentiated Neuroendocrine Tumors, Bronchial Neoplasms, +28 more
Locations
  • California Pacific Medical Center Drug Shipment (2) San Francisco, California, United States
  • Hematology Oncology Associates of the Treasure Coast Port Saint Lucie, Florida, United States
  • University Cancer and Blood Center, LLC Athens, Georgia, United States
  • Northwestern University Medical School Chicago, Illinois, United States
View all 20 locations
View Trial Details
Completed

Immune Boost In Non-Small Cell Lung Cancer

NCT02319408

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Department of Thoracic Surgery, Thoraxklinik, University Hospital Heidelberg Heidelberg, Germany
  • German Cancer Research Centre and Clinic for Radiation Oncology of the University of Heidelberg Heidelberg, Germany
View Trial Details

Related conditions